Klow 80mg*10 vials (50mg ghk-cu, 10mg tb-500, 10mg bpc-157, 10mg kpv)

Description

Introduction

Klow 80mg is a multi-peptide research formulation combining four well-characterized bioactive peptides studied extensively in laboratory research involving extracellular matrix regulation, tissue repair signaling, anti-inflammatory pathway modulation, and cellular migration biology. As a compound combination of significant scientific interest, Klow 80mg is used by researchers investigating the individual and potential synergistic interactions between GHK-Cu, TB-500, BPC-157, and KPV in controlled experimental models.

What Is the Klow Blend?

Klow 80mg is a research-grade quad-peptide complex supplied as a lyophilized powder, each vial containing a precisely measured combination of four bioactive peptides. GHK-Cu (50mg) is a copper-binding tripeptide studied for its role in collagen synthesis and extracellular matrix gene expression modulation. TB-500 (10mg) is a Thymosin Beta-4 derived peptide examined for its actin-binding and cellular migration pathway effects. BPC-157 (10mg) is a gastric pentadecapeptide investigated for nitric oxide signaling and cytoprotective mechanisms. KPV (10mg) is a tripeptide derived from alpha-MSH studied for its anti-inflammatory cytokine modulation properties.

Structure and Function

Each vial of Klow 80mg contains GHK-Cu (50mg), TB-500 (10mg), BPC-157 (10mg), and KPV (10mg) in lyophilized form. The combined formulation enables researchers to study the individual mechanisms of each peptide alongside their potential overlapping or synergistic effects on shared regenerative, anti-inflammatory, and angiogenic signaling pathways in controlled laboratory systems.

Research Applications

Klow 80mg is of interest across several areas of scientific investigation, including:

• Multi-pathway peptide signaling and synergistic compound interaction investigation in controlled experimental models
• Extracellular matrix synthesis and collagen production research in fibroblast cell culture systems
• Cellular migration, actin cytoskeletal regulation, and angiogenesis pathway studies in tissue biology research
• Anti-inflammatory cytokine modulation and melanocortin receptor pathway interaction investigation
• Nitric oxide and cytoprotective mechanism studies across tissue type-specific laboratory models

Research Findings and Scientific Interest

Studies have individually characterized GHK-Cu, TB-500, BPC-157, and KPV across regenerative biology, tissue repair, and anti-inflammatory research contexts, with growing interest in their combined application for multi-pathway peptide interaction studies in laboratory models. Research into the synergistic and additive biological effects of this four-peptide combination continues to attract interest from the regenerative medicine and peptide biology research communities. The standardized quad-peptide formulation supports reproducible comparative investigation designs.

Availability and Specifications

Klow 80mg is available in lyophilized powder form at 80mg per vial (50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, 10mg KPV), supplied as 10 vials per set, for use in controlled laboratory environments by qualified researchers.

This product is intended strictly for laboratory research purposes only. It is not intended for human consumption or for medical, veterinary, or therapeutic use.